Citi Upgrades ProQR Therapeutics N.V. (PRQR) to Buy
Tweet
Share
E-mailGet Alerts PRQR Hot Sheet
Price: $1.92 +3.78%
Rating Summary:
12 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
12 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Citi analyst Yigal Nochomovitz upgraded ProQR Therapeutics N.V. (NASDAQ: PRQR) from Neutral to Buy with a price target of $4.00.
For an analyst ratings summary and ratings history on ProQR Therapeutics N.V. click here. For more ratings news on ProQR Therapeutics N.V. click here.
Shares of ProQR Therapeutics N.V. closed at $1.94 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stripe, Advent In Talks To Buy Paypal - WSJ
- Jefferies on Five Below (FIVE): 'Our latest channel checks reinforce our view that FIVE's momentum extends well beyond viral Squish trends'
- Freedom Broker Upgrades Serve Robotics (SERV) to Buy
Create E-mail Alert Related Categories
UpgradesRelated Entities
Citi, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
